Jen-Chieh Chuang

Company: Takeda Pharmaceutical

Job title: Program, Translational Medicine & Biomarker Lead

Seminars:

Leveraging Proteomics to Identify Treatment-Responsive Biomarkers in a Rare Genetic Fibrotic Liver Disease (AATD-LD) 4:30 pm

Explore how high-throughput Olink proteomics and single-nucleus RNA sequencing (Snucseq) can be combined to map dynamic changes in protein expression across liver cell types in response to therapy Highlight treatment responsive individual proteins and pathways involved in cell stress, inflammation, and ECM remodeling Discuss the translational relevance of circulating biomarkers as indicators of therapeutic response…Read more

day: Conference Day One